海普瑞：2024年報.pdf

1、 Annual Report年度報告(A joint stock company incorporated in the Peoples Republic of China with limited liability)Stock Code 股份代號:9989（於中華人民共和國註冊成立的股份有限公司）2024年度報告Annual Report 2024Corporate Information 2公司資料Financial Highlights 5財務摘要Chairmans Statement 6董事長致辭Management Discussion and Analysis 9管理層討論與分析

2、Directors,Supervisors and Senior Management 24董事、監事及高級管理層Directors Report 29董事會報告Corporate Governance Report 53企業管治報告Independent Auditors Report 75獨立核數師報告Consolidated Statement of Profit or Loss 85綜合損益表Consolidated Statement of Comprehensive Income 86綜合全面收益表Consolidated Statement of Financial Positi

3、on 87綜合財務狀況表Consolidated Statement of Changes in Equity 89綜合權益變動表Consolidated Statement of Cash Flows 91綜合現金流量表Notes to Financial Statements 94財務報表附註CONTENTS目 錄SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO.,LTD.深圳市海普瑞藥業集團股份有限公司2Corporate Information公司資料Board of DirectorsExecutive DirectorsMr.Li Li(Chair

4、man)Ms.Li Tan(Deputy General Manager)Mr.Shan Yu(General Manager)Mr.Zhang PingIndependent Non-executive DirectorsDr.Lu ChuanMr.Huang PengMr.Yi MingJoint Company SecretariesMr.Qian FengqiMs.Chan Sze Ting(FCG,HKFCG)Authorized RepresentativesMr.Qian FengqiMs.Chan Sze TingSupervisorsMr.Zheng Zehui(Chairm

5、an)Ms.Tang HaijunMs.Su Jilan(Employee Supervisor)Strategy CommitteeMr.Li Li(Chairman)Ms.Li TanDr.Lu ChuanRemuneration and Evaluation CommitteeMr.Yi Ming(Chairman)Mr.Li LiMr.Huang Peng董事會執行董事李鋰先生（董事長）李坦女士（副總經理）單宇先生（總經理）張平先生獨立非執行董事呂川博士黃鵬先生易銘先生聯席公司秘書錢風奇先生陳詩婷女士（FCG,HKFCG）授權代表錢風奇先生陳詩婷女士監事鄭澤輝先生（主席）唐海均女士蘇紀

6、蘭女士（職工監事）戰略委員會李鋰先生（主席）李坦女士呂川博士薪酬與考核委員會易銘先生（主席）李鋰先生黃鵬先生Annual Report 2024 年度報告3Corporate Information公司資料Audit CommitteeMr.Huang Peng(Chairman)Dr.Lu ChuanMr.Yi MingNomination CommitteeDr.Lu Chuan(Chairman)Mr.Li LiMs.Li Tan(appointed on March 31,2025)Mr.Yi MingRegistered OfficeNo.21 Langshan RoadNansha